Table 4.

Type of new-onset immune-mediated inflammatory disease (IMID), N=33

New-onset IMID	N (%) of patients	Vaccine doses before IMID onset N (%) of patients
		1	2	3
Pericarditis	5 (14)	0	4 (80)	1 (20)
Polymyalgia rheumatica	4 (11)	0	0	4 (100)
Vasculitis*	4 (11)	1 (25)	2 (50)	1 (25)
Undifferentiated arthritis	3 (8)	1 (33)	1 (33)	1 (33)
Autoimmune thrombocytopaenia	3 (8)	1 (33)	1 (33)	1 (33)
Anti-phospholipid syndrome	2 (5)	1 (50)	1 (50)	0
Psoriatic arthritis	2 (5)	1 (50)	1 (50)	0
Spondyloarthritis	2 (5)	1 (50)	1 (50)	0
Rheumatoid arthritis	2 (5)	2 (100)	0	0
Ulcerative colitis	1 (3)	0	1 (100)	0
Adult-onset autoimmune enteropathy	1 (3)	0	1 (100)	0
Crystal arthritis	1 (3)	0	1 (100)	0
Cholangitis	1 (3)	0	1 (100)	0
Autoimmune thyroiditis	1 (3)	0	1 (100)	0
Optic neuritis	1 (3)	1 (100)	0	0

*n=1 Giant cell arteritis, n=1 IgA vasculitis (Schönlein-Henoch), n=1 leucocytoclastic vasculitis, n=1 microscopic polyangiitis.